MARKET

CLSN

CLSN

Celsion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.646
+0.026
+1.60%
After Hours: 1.630 -0.016 -0.97% 17:07 01/17 EST
OPEN
1.620
PREV CLOSE
1.620
HIGH
1.680
LOW
1.620
VOLUME
98.71K
TURNOVER
--
52 WEEK HIGH
2.630
52 WEEK LOW
1.050
MARKET CAP
37.29M
P/E (TTM)
-4.5898
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CLSN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CLSN News

  • Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
  • Zacks.3d ago
  • Momenta (MNTA) Provides Pipeline Updates, Stock Rallies
  • Zacks.3d ago
  • Ultragenyx Provides Preliminary Crysvita 2019 Revenues
  • Zacks.4d ago
  • Applied Therapeutics Up on Positive Galactosemia Study Data
  • Zacks.01/09 21:47

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About CLSN

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
More

Webull offers Celsion Corporation (CLSN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.